Evidence map›Paper›PMID 42487902›Full record

ArticleNeuro-oncology advances

Multi-threshold volumetric

Thura Tun Oo, Shaun D Grega, Nathaniel J Smith, Tristan K Deaton, Keith G Ciantar, Wendy Territo, Lu Mao, Sharon Sidenbender, Jesus A Ocana, Matthew E Larson and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Thura Tun OoSchool of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0003-1367-5157
Shaun D GregaIndiana University School of Medicine, Indianapolis, Indiana, USA.
Nathaniel J SmithIndiana University School of Medicine, Indianapolis, Indiana, USA.
Tristan K DeatonIndiana University School of Medicine, Indianapolis, Indiana, USA.
Keith G CiantarInstitute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.
Wendy TerritoIndiana University School of Medicine, Indianapolis, Indiana, USA.
Lu MaoSchool of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0002-8626-9822
Sharon SidenbenderIndiana University School of Medicine, Indianapolis, Indiana, USA.
Jesus A OcanaIndiana University School of Medicine, Indianapolis, Indiana, USA.
Matthew E LarsonSchool of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Mark TannIndiana University School of Medicine, Indianapolis, Indiana, USA.
Kathryn NevelIndiana University School of Medicine, Indianapolis, Indiana, USA.
Brian D GranerIndiana University School of Medicine, Indianapolis, Indiana, USA.
Gary D HutchinsIndiana University School of Medicine, Indianapolis, Indiana, USA.
Mark A GreenIndiana University School of Medicine, Indianapolis, Indiana, USA.
Philipp LohmannInstitute of Neuroscience and Medicine (INM-3, INM-4), Research Center Juelich, Juelich, Germany.ORCID https://orcid.org/0000-0002-5360-046X
Michael C VeronesiSchool of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-8551-151X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Amino acid PET with Methods: This retrospective single-institution study included 100 previously treated glioma patients (WHO Grade 2-4) who underwent Results: TBRthres map generation was highly reproducible (ICC > 0.86) and significantly associated with overall survival in univariate analyses (HR range: 3.07-4.45). Volumetric metrics demonstrated diagnostic performance comparable to TBRmax (AUC up to 0.91). TBRmax showed moderate correlation with tumor volume ( Conclusion: Volumetric

Indexed as

18F-FETbrain tumorgliomaimagingPET

Identifiers

PMID42487902
PMCPMC13391156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.